Zobrazeno 1 - 10
of 235
pro vyhledávání: '"Daniel, Margolis"'
Autor:
Jonathan J Deeks, Chris Brew-Graves, Yemisi Takwoingi, Aiman Haider, Clare Allen, Alex Freeman, Mark Emberton, Antti Rannikko, John Wilkinson, Daniel Margolis, Enrique Gomez Gomez, Sangeet Ghai, Alex Kirkham, Veeru Kasivisvanathan, Caroline M Moore, Hazel McBain, Anders Bjartell, Paula Lorgelly, Pramit Khetrapal, Shonit Punwani, Nicola Muirhead, Ridhi Agarwal, Philip Ryan, Caroline S Clarke, Aqua Asif, Peter Albertsen, Alexander Ng, Francesco Giganti, Louise Dickinson, Jeremy Grummet, Vinson Wai-Shun Chan, Arjun Nathan, Marimo Rossiter, Réka Novotta, Tushar Narain, Antonette Andrews, Valeria Panebianco, Lance Mynderse, Adam Froemming, Naoki Takahasi, Tristan Barrett, Raphaële Renard-Penna, Vibeke Løgager, Lars Boesen, Lars Budäus, Tho Pham, Jing Yi Jessica Weng, Wim Witjes, Christien Caris, Joke Van Egmond
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction Prostate MRI is a well-established tool for the diagnostic work-up for men with suspected prostate cancer (PCa). Current recommendations advocate the use of multiparametric MRI (mpMRI), which is composed of three sequences: T2-weighted s
Externí odkaz:
https://doaj.org/article/dbc4c0513c464951a792aa55f3321290
Autor:
Juana Martinez, Kritika Subramanian, Daniel Margolis, Elisabeth O'Dwyer, Joseph Osborne, Yuliya Jhanwar, Himanshu Nagar, Nicholas Williams, Arindam RoyChoudhury, Gabriela Madera, John Babich, Sandra Huicochea Castellanos
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101242- (2022)
Background: The primary objective was to compare the overall diagnostic performance, presented as detection rate of 68Ga-PSMA-HBED-CC positron emission tomography/magnetic resonance imaging (PSMA PET/MRI) versus conventional, multiparametric MRI (mpM
Externí odkaz:
https://doaj.org/article/d82a1ce971a34dff967ae2e5b48f87b2
Autor:
Christina Sze, Zorawar Singh, Ananth Punyala, Poorvi Satya, Molly Sadinski, Ramkrishnan Narayan, Aleksander Nacev, Dinesh Kumar, John Adams, Kathryn Nicholas, Daniel Margolis, Bilal Chughtai
Publikováno v:
The Prostate. 83:656-662
Autor:
Liang Ma, Zehua Chen, Da Wei Huang, Ousmane H. Cissé, Jamie L. Rothenburger, Alice Latinne, Lisa Bishop, Robert Blair, Jason M. Brenchley, Magali Chabé, Xilong Deng, Vanessa Hirsch, Rebekah Keesler, Geetha Kutty, Yueqin Liu, Daniel Margolis, Serge Morand, Bapi Pahar, Li Peng, Koen K. A. Van Rompay, Xiaohong Song, Jun Song, Antti Sukura, Sabrina Thapar, Honghui Wang, Christiane Weissenbacher-Lang, Jie Xu, Chao-Hung Lee, Claire Jardine, Richard A. Lempicki, Melanie T. Cushion, Christina A. Cuomo, Joseph A. Kovacs
Publikováno v:
mBio, Vol 11, Iss 2 (2020)
ABSTRACT Pneumocystis, a major opportunistic pathogen in patients with a broad range of immunodeficiencies, contains abundant surface proteins encoded by a multicopy gene family, termed the major surface glycoprotein (Msg) gene superfamily. This supe
Externí odkaz:
https://doaj.org/article/506cf3cdb75d42c089e62b4f90d2fba5
Autor:
Thaer A. Daifallah, Daniel Margolis
Publikováno v:
Atlas of Operative Oral and Maxillofacial Surgery. :619-636
Autor:
Kareem Elfatairy, Hreedi Dev, Ashkan Heshmatzade Behzadi, Ari Jonisch, Ayah Megahed, Anas Bamashmos, Martin R. Prince, Hanieh Attari, Jinhye Kim, Syed Imran Raza, Sadjad Riyahi, Daniel Margolis
Publikováno v:
Radiology. 301:E426-E433
Background Pulmonary embolism (PE) commonly complicates SARS-CoV-2 infection but there is heterogeneity in incidence and mortality in the single center reports and risk factors. Purpose To determine the incidence of PE in COVID-19 and its association
Autor:
Daniel Margolis
Publikováno v:
Radiol Imaging Cancer
Autor:
Christine Chen, Daniel Margolis
Publikováno v:
Seminars in Roentgenology. 56:376-383
Prostate cancer is projected to remain the second leading cause of cancer-related death in men in the United States in 2021[1]. Traditionally, initial staging and post-treatment surveillance require a variety of imaging exams, from bone scan and CT t
Autor:
Varaha S Tammisetti, Peter-Paul Willemse, Daniel Rukstalis, Veeru Kasivisvanathan, Xavier Cathelineau, Yoh Matsuoka, Willemien Van Den Bos, Giorgio Gandaglia, Soroush Rais-Bahrami, Takumi Shiraishi, Massimo Valerio, Ardeshir R. Rastinehad, Cary N. Robertson, Herbert Lepor, Rajan T Gupta, Juan Gomez Rivas, Toshitaka Shin, Ariel Schulman, Yann Barbe, A.L. Abreu, Marco Moschini, Arvin K. George, Marco Oderda, Armando Stabile, Amir H. Lebastchi, Nathan Lawrentschuk, Daniel Margolis, Georg Salomon, M.P. Laguna, Wei Phin Tan, Jean J.M.C.H. de la Rosette, Derek Lomas, Christian P Pavlovich, Hazem Orabi, Bernard Malavaud, Abhinav Sidana, Osamu Ukimura, Sherif Mehralivand, Justin Gregg, Fernando Bianco, Thomas J. Polascik, Jochen Walz, Giancarlo Marra, Petr Macek, Rafael Sanchez-Salas, Sunao Shoji, Mesut Remzi, A. Villers
Publikováno v:
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica S.p.A.
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica
Background Focal Therapy (FT) for Prostate Cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in selecting, treating and following u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5674c39c2c1157340f1c0353262367
https://pure.amc.nl/en/publications/molecular-biomarkers-in-the-context-of-focal-therapy-for-prostate-cancer(df7bf651-87c7-44e5-bf47-9d2e9141567d).html
https://pure.amc.nl/en/publications/molecular-biomarkers-in-the-context-of-focal-therapy-for-prostate-cancer(df7bf651-87c7-44e5-bf47-9d2e9141567d).html
Autor:
Daniel Margolis, Stefanie J. Hectors, Elizabeth M. Sweeney, Jim C. Hu, Zihan Yang, Christine Chen
Publikováno v:
Abdominal Radiology. 46:5369-5376
Prostate heterogeneity on multi-parametric MRI (mpMRI) may confound image interpretation by obscuring lesions; systematic biopsy may have a role in this context. To determine if prostate heterogeneity (1) correlates with clinical risk factors for pro